99 related articles for article (PubMed ID: 3761321)
61. Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.
Paganoni R; Herzog C; Braunsteiner A; Hohl P
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():3-17. PubMed ID: 3144545
[TBL] [Abstract][Full Text] [Related]
62. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
[TBL] [Abstract][Full Text] [Related]
63. [Current antimicrobial agent series III: Norfloxacin].
Ueda Y; Matsumoto F
Jpn J Antibiot; 1988 Jul; 41(7):782-96. PubMed ID: 3050183
[No Abstract] [Full Text] [Related]
64. Facile heterocyclic synthesis and antimicrobial activity of polysubstituted and condensed pyrazolopyranopyrimidine and pyrazolopyranotriazine derivatives.
Hafez HN; Alshammari AG; El-Gazzar AR
Acta Pharm; 2015 Dec; 65(4):399-412. PubMed ID: 26677897
[TBL] [Abstract][Full Text] [Related]
65. [Laboratory and clinical studies on norfloxacin in the pediatric field].
Toyonaga Y; Koizumi M; Imai H; Sakaguchi N; Sugita M; Fukushima Y; Yamasaki M
Jpn J Antibiot; 1990 May; 43(5):808-25. PubMed ID: 2391752
[TBL] [Abstract][Full Text] [Related]
66. Bactericidal and antineoplastic effect of combination of norfloxacin and adriamycin.
Castelli M; Barbieri ML; Bertolini A; Bossa R; Galatulas I
Chemotherapy; 1987; 33(5):355-60. PubMed ID: 3665634
[TBL] [Abstract][Full Text] [Related]
67. [Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
Rahal K
Arch Inst Pasteur Alger; 1989; 57():213-48. PubMed ID: 2489401
[TBL] [Abstract][Full Text] [Related]
68. [Effect of norfloxacin on bacterial flora in human feces].
Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T
Jpn J Antibiot; 1987 Sep; 40(9):1584-616. PubMed ID: 3694785
[TBL] [Abstract][Full Text] [Related]
69. [Laboratory and clinical studies of norfloxacin in respiratory tract infections].
Kuwabara M; Muroki K; Fujiue Y; Ikeda M; Kodomari Y; Jyo T; Yamakido M
Jpn J Antibiot; 1988 Jan; 41(1):1-9. PubMed ID: 3367509
[TBL] [Abstract][Full Text] [Related]
70. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
Galante D; Pennucci C; Esposito S; Barba D
Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and characterization of N-Mannich based prodrugs of ciprofloxacin and norfloxacin:
Piplani M; Rajak H; Sharma PC
J Adv Res; 2017 Jul; 8(4):463-470. PubMed ID: 28721301
[TBL] [Abstract][Full Text] [Related]
72. Photoswitchable Antibiotic Hybrids: Spacer Length-Dependent Photochemical Control of Antibacterial Activity.
Bhunia S; Das A; Jana SK; Mandal S; Samanta S
Bioconjug Chem; 2024 Jan; 35(1):92-98. PubMed ID: 38111208
[TBL] [Abstract][Full Text] [Related]
73. Synthesis, physiochemical properties, photochemical probe, and antimicrobial effects of novel norfloxacin analogues.
Bakhotmah DA; Abdul-Rahman RM; Makki MS; El-Zahabi MA; Suliman M
ISRN Org Chem; 2011; 2011():184754. PubMed ID: 24052816
[TBL] [Abstract][Full Text] [Related]
74. Case 43-1988.
Neu HC
N Engl J Med; 1989 Apr; 320(17):1148. PubMed ID: 2710182
[No Abstract] [Full Text] [Related]
75. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
[TBL] [Abstract][Full Text] [Related]
76. Studies on prodrugs. 5. Synthesis and antimicrobial activity of N-(oxoalkyl)norfloxacin derivatives.
Kondo H; Sakamoto F; Kodera Y; Tsukamoto G
J Med Chem; 1986 Oct; 29(10):2020-4. PubMed ID: 3761321
[TBL] [Abstract][Full Text] [Related]
77. Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives.
Kondo H; Sakamoto F; Kawakami K; Tsukamoto G
J Med Chem; 1988 Jan; 31(1):221-5. PubMed ID: 3275778
[TBL] [Abstract][Full Text] [Related]
78. Studies on prodrugs. 11. Synthesis and antimicrobial activity of N-[(4-methyl-5-methylene-2-oxo-1,3-dioxolan-4-yl)oxy]norfloxacin .
Kondo H; Sakamoto F; Uno T; Kawahata Y; Tsukamoto G
J Med Chem; 1989 Mar; 32(3):671-4. PubMed ID: 2645402
[TBL] [Abstract][Full Text] [Related]
79. Synthesis, degradation, and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin.
Roseeuw E; Coessens V; Balazuc AM; Lagranderie M; Chavarot P; Pessina A; Neri MG; Schacht E; Marchal G; Domurado D
Antimicrob Agents Chemother; 2003 Nov; 47(11):3435-41. PubMed ID: 14576099
[TBL] [Abstract][Full Text] [Related]
80. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Holmes B; Brogden RN; Richards DM
Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
